125 related articles for article (PubMed ID: 35579910)
21. Ocular Delivery of Metformin for Sustained Release and in Vivo Efficacy.
Regu VPR; Behera D; Sunkara SP; Gohel V; Tripathy S; Swain RP; Subudhi BB
J Pharm Sci; 2023 Sep; 112(9):2494-2505. PubMed ID: 37031863
[TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of thermosensitive flurbiprofen
Maddiboyina B; Jhawat V; Desu PK; Gandhi S; Nakkala RK; Singh S
J Biomater Sci Polym Ed; 2021 Aug; 32(12):1584-1597. PubMed ID: 33977874
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting on
Al Gawhari FJ
J Adv Pharm Technol Res; 2023; 14(4):294-298. PubMed ID: 38107457
[TBL] [Abstract][Full Text] [Related]
24. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
Srividya B; Cardoza RM; Amin PD
J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
[TBL] [Abstract][Full Text] [Related]
25. Protein Nanoparticles Laden
Pillai AR; Prajapati B; Dharamsi A
Curr Drug Deliv; 2024; 21(1):38-51. PubMed ID: 36694323
[TBL] [Abstract][Full Text] [Related]
26. Electrospun nanofibers - A promising solid in-situ gelling alternative for ocular drug delivery.
Göttel B; de Souza E Silva JM; Santos de Oliveira C; Syrowatka F; Fiorentzis M; Viestenz A; Viestenz A; Mäder K
Eur J Pharm Biopharm; 2020 Jan; 146():125-132. PubMed ID: 31816391
[TBL] [Abstract][Full Text] [Related]
27. A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir.
Li P; Wang S; Chen H; Zhang S; Yu S; Li Y; Cui M; Pan W; Yang X
Drug Dev Ind Pharm; 2018 May; 44(5):829-836. PubMed ID: 29212376
[TBL] [Abstract][Full Text] [Related]
28. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
29. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.
Morsi N; Ibrahim M; Refai H; El Sorogy H
Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750
[TBL] [Abstract][Full Text] [Related]
30. An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Pharm Bioallied Sci; 2015; 7(1):9-14. PubMed ID: 25709330
[TBL] [Abstract][Full Text] [Related]
31. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
Gupta H; Velpandian T; Jain S
J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
[TBL] [Abstract][Full Text] [Related]
32. Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis.
Deepthi S; Jose J
Int Ophthalmol; 2019 Jun; 39(6):1355-1366. PubMed ID: 29922978
[TBL] [Abstract][Full Text] [Related]
33. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
Ma WD; Xu H; Wang C; Nie SF; Pan WS
Int J Pharm; 2008 Feb; 350(1-2):247-56. PubMed ID: 17961940
[TBL] [Abstract][Full Text] [Related]
34. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
Ma WD; Xu H; Nie SF; Pan WS
Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
[TBL] [Abstract][Full Text] [Related]
35. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
[TBL] [Abstract][Full Text] [Related]
37. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel.
Pandurangan DK; Bodagala P; Palanirajan VK; Govindaraj S
Int J Pharm Investig; 2016; 6(1):56-62. PubMed ID: 27014620
[TBL] [Abstract][Full Text] [Related]
40. A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluation.
Zhu L; Ao J; Li P
Drug Des Devel Ther; 2015; 9():3943-9. PubMed ID: 26251573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
